Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, Calif; Cardiovascular Research Institute, University of California, San Francisco, Calif.
Cardiovascular Research Institute, University of California, San Francisco, Calif.
J Allergy Clin Immunol. 2014 Feb;133(2):388-94. doi: 10.1016/j.jaci.2013.07.036. Epub 2013 Sep 24.
The 3-gene signature of periostin, chloride channel accessory 1 (CLCA1), and Serpin β2 (SERPINB2) in airway epithelial brushings is used to classify asthma into TH2-high and TH2-low endotypes. Little is known about the utility of gene profiling in sputum as a molecular phenotyping method.
We sought to determine whether gene profiling in sputum cells can identify T(H)2-high and T(H)2-low subtypes of asthma.
In induced sputum cell pellets from 37 asthmatic patients and 15 healthy control subjects, PCR was used to profile gene expression of the epithelial cell signature of IL-13 activation (periostin, CLCA1, and SERPINB2), TH2 genes (IL4, IL5, and IL13), and other genes associated with airway TH2 inflammation.
Gene expression levels of CLCA1 and periostin, but not SerpinB2, were significantly higher than normal in sputum cells from asthmatic subjects. Expression levels of IL-4, IL-5, and IL-13 were also significantly increased in asthmatic patients and highly correlated within individual subjects. By combining the expression levels of IL-4, IL-5, and IL-13 in a single quantitative metric ("T(H)2 gene mean"), 26 (70%) of the 37 asthmatic patients had T(H)2-high asthma, which was characterized by more severe measures of asthma and increased blood and sputum eosinophilia. TH2 gene mean values tended to be stable when initial values were very high or very low but fluctuated above or below the T(H)2-high cutoff when initial values were intermediate.
IL-4, IL-5, and IL-13 transcripts are easily detected in sputum cells from asthmatic patients, and their expression levels can be used to classify asthma into T(H)2-high and T(H)2-low endotypes.
在外周气道上皮刷检物中,骨桥蛋白、氯离子通道辅助蛋白 1(CLCA1)和丝氨酸蛋白酶抑制剂β2(SERPINB2)的 3 基因标志物用于将哮喘分为 TH2 高和 TH2 低表型。关于痰液基因谱作为一种分子表型方法的应用知之甚少。
我们旨在确定痰液细胞基因谱是否可识别 TH2 高和 TH2 低表型哮喘。
在 37 例哮喘患者和 15 例健康对照者的诱导痰细胞沉淀中,采用聚合酶链反应(PCR)对 IL-13 激活的上皮细胞标志物(骨桥蛋白、CLCA1 和 SERPINB2)、TH2 基因(IL4、IL5 和 IL13)和其他与气道 TH2 炎症相关的基因进行基因表达谱分析。
与健康对照者相比,哮喘患者的 CLCA1 和骨桥蛋白基因表达水平显著升高,而 SERPINB2 则无显著差异。哮喘患者的 IL-4、IL-5 和 IL-13 表达水平也显著升高,且在个体患者中高度相关。通过将 IL-4、IL-5 和 IL-13 的表达水平合并为单个定量指标(“TH2 基因均值”),37 例哮喘患者中有 26 例(70%)为 TH2 高表型哮喘,其特点是哮喘严重程度更严重,且血液和痰液嗜酸性粒细胞增多。当初始值非常高或非常低时,TH2 基因均值趋于稳定,但当初始值处于中间值时,其值则在 TH2 高截断值以上或以下波动。
IL-4、IL-5 和 IL-13 转录本在哮喘患者的痰细胞中容易检测到,其表达水平可用于将哮喘分为 TH2 高和 TH2 低表型。